Cogstate Announces Formation of Scientific Advisory Board
14 juin 2022 10h52 HE
|
Cogstate Ltd.
Melbourne, VIC, Australia; New Haven, CT, USA, June 14, 2022 (GLOBE NEWSWIRE) -- Cogstate (ASX.CGS) a leading neuroscience technology company, today announced the formation of a Scientific Advisory...
EISAI TO LAUNCH DIGITAL TOOL "CogMate™ IN TAIWAN AND HONG KONG
12 janv. 2022 21h19 HE
|
Cogstate Ltd.
Melbourne, VIC, Australia; New Haven, CT, USA, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Cogstate (ASX.CGS), via its global commercial partner Eisai Co., Ltd, is pleased to announce that Cogstate technology...
Clinical Trial in Dementia with Lewy Bodies Used Cogstate Digital Assessments and Data Quality Services to Support the Evaluation of Neflamapimod
01 déc. 2021 11h33 HE
|
Cogstate Ltd.
Melbourne, VIC, Australia; New Haven, CT, USA, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Neuroscience technology company, Cogstate Ltd (ASX.CGS), announced its digital cognitive assessments were part of the...
Leaders from Cogstate Join the Davos Alzheimer’s Collaborative to Accelerate Innovation and Preparedness for Disease Interventions
16 nov. 2020 07h48 HE
|
Cogstate Ltd.
Melbourne, VIC, Australia; New Haven, CT, USA, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Neuroscience technology company, Cogstate Ltd (ASX.CGS), announced today that four members of its executive...
Cogstate Expands Executive Team with Key Scientific Appointments
01 oct. 2020 08h00 HE
|
Cogstate Ltd.
Melbourne, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Neuroscience technology company, Cogstate Ltd (ASX.CGS), announced today the appointment of Chris Edgar, PhD as Chief Science Officer and Prof. Paul...
Cogstate Receives Digital Biomarker Award from ADDF to Develop Mobile App for Early Detection of Memory Impairment
29 avr. 2020 10h30 HE
|
Cogstate Ltd.
Melbourne, VIC, Australia; New Haven, CT, USA, April 29, 2020 (GLOBE NEWSWIRE) -- Cogstate Ltd (ASX:CGS) today announced an award from the Alzheimer's Drug Discovery Foundation’s (ADDF) Diagnostics...
Cogstate Expands Executive Team, Appointing Ken Billard as Chief Commercial Officer
19 nov. 2019 08h00 HE
|
Cogstate Ltd.
New Haven, CT, Nov. 19, 2019 (GLOBE NEWSWIRE) -- The neuroscience technology company, Cogstate Ltd (ASX.CGS), announced today that Ken Billard has joined the company in the role of Chief Commercial...
Cogstate Establishes Rare Disease and Pediatric Center of Excellence
05 avr. 2018 09h16 HE
|
Cogstate Ltd.
New Haven, CT, April 05, 2018 (GLOBE NEWSWIRE) -- The cognitive science company, Cogstate Ltd (ASX.CGS) today announced the establishment of a Rare Disease and Pediatric Center of Excellence to lead...